Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:11 PM
Ignite Modification Date:
2025-12-24 @ 4:11 PM
NCT ID:
NCT04110366
Eligibility Criteria:
Inclusion Criteria:
* Capacity to provide written informed consent
* Aged 18-30 years (inclusive)
* Fluent English speaker
Exclusion Criteria:
* Current involvement in another study unless observational or in follow-up phase (non-interventional)
* Received any influenza vaccine over the last 2 years
* Egg allergy
* Previous significant adverse reaction to any vaccination/immunisation
* Current regular (daily) smoker
* Pregnant
* Any medication that may affect the immune system (e.g. steroids)
* Taking regular acetylsalicylic acid (aspirin)
* Unable to give informed consent
* Current acute severe febrile illness
* Taking long term antibiotics
* Clinically diagnosed influenza in the last 2 years
* Any long-term health problem with heart disease, lung disease (including asthma), kidney disease, neurologic disease, liver disease, metabolic disease (e.g. diabetes) or anemia or another blood disorder
* Use of drugs for the treatment of rheumatoid arthritis, Crohn's disease, or psoriasis or anticancer drugs; or radiation treatments
* History of Guillain-Barre syndrome
* Live with or expect to have close contact with a person whose immune system is severely compromised and who must be in protective isolation (e.g., an isolation room of a bone marrow transplant unit)
* Received any other vaccinations in the past 4 weeks
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
30 Years
Study:
NCT04110366
Study Brief:
Protocol Section:
NCT04110366